A detailed history of Pnc Financial Services Group, Inc. transactions in Gamida Cell Ltd. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 5,500 shares of GMDA stock, worth $165. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,500
Previous 5,500 -0.0%
Holding current value
$165
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.85 - $1.87 $4,675 - $10,285
5,500 New
5,500 $5,000

Others Institutions Holding GMDA

About Gamida Cell Ltd.


  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.